Special Committees

The Audit and Risk Management Committee

In line with today’s international trends in corporate governance, the company has established an Audit and Risk Management Committee to ensure professional attention, sound corporate governance system, enhanced competitiveness, and full compliance with government specifications related to the company’s public listing. This committee is composed of independent directors qualified for their financial, accounting, legal, intellectual property, research and other professional backgrounds. The purpose of this independent committee is to assist the Board in its audit-related decisions.

Howard S. Lee, Ph.D.

Independent Director

Chin-Ting Chiu

Independent Director

Dr. TAI-TSANG CHEN

Independent Director

The Remuneration and Nomination Committee

OBI’s compensation and remuneration system is a priority that fully complies with the corporate governance and risk management guidelines for listed companies established by the appropriate Taiwan government agencies. This “Remuneration and Nomination Committee” of the Board of Directors consists of external members appointed for their objectivity and their professional qualifications. The committee assesses the salary remuneration policy and related systems for OBI’s directors, supervisors, and managers and makes recommendations to the Board for its careful consideration. 

Howard S. Lee, Ph.D.

Independent Director

Chin-Ting Chiu

Independent Director

Dr. TAI-TSANG CHEN

Independent Director

Sustainability Development Committee

To fulfill the company’s sustainability goals and strengthen governance effectiveness, OBI Pharma has established the Sustainability Development Committee under the Board of Directors in accordance with the Corporate Governance Best-Practice Principles and the Sustainable Development Best-Practice Principles. The committee is composed of no fewer than three members appointed by the Board, with at least one director participating in supervision. All members are required to possess relevant expertise and competencies in sustainability.
The committee is primarily responsible for formulating and promoting the company’s sustainability policies, annual plans, and strategies; regularly reviewing implementation performance; overseeing sustainability disclosures and the preparation of the sustainability report; and supervising sustainability-related matters as resolved by the Board. The committee may also appoint senior executives and establish dedicated or cross-functional working groups, as needed, to ensure the effective implementation of sustainability initiatives.

Kung-Yee Liang, Ph.D.

Chairman

Heidi Wang, Ph. D.

Director and Chief Executive Officer

Colin Kao

Chief Operating Officer